DE602007014210D1 - Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen - Google Patents

Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen

Info

Publication number
DE602007014210D1
DE602007014210D1 DE602007014210T DE602007014210T DE602007014210D1 DE 602007014210 D1 DE602007014210 D1 DE 602007014210D1 DE 602007014210 T DE602007014210 T DE 602007014210T DE 602007014210 T DE602007014210 T DE 602007014210T DE 602007014210 D1 DE602007014210 D1 DE 602007014210D1
Authority
DE
Germany
Prior art keywords
protein
prophylactic
therapeutic agent
neurodegenerative diseases
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007014210T
Other languages
English (en)
Inventor
Hitoshi Okazawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tokyo Medical and Dental University NUC
Original Assignee
Tokyo Medical and Dental University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Medical and Dental University NUC filed Critical Tokyo Medical and Dental University NUC
Publication of DE602007014210D1 publication Critical patent/DE602007014210D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
DE602007014210T 2006-06-01 2007-04-24 Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen Active DE602007014210D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006154059A JP4982739B2 (ja) 2006-06-01 2006-06-01 ポリグルタミン病の予防・治療剤
PCT/JP2007/058873 WO2007138810A1 (ja) 2006-06-01 2007-04-24 神経変性疾患の予防・治療剤

Publications (1)

Publication Number Publication Date
DE602007014210D1 true DE602007014210D1 (de) 2011-06-09

Family

ID=38778331

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007014210T Active DE602007014210D1 (de) 2006-06-01 2007-04-24 Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen

Country Status (6)

Country Link
US (1) US7833975B2 (de)
EP (1) EP2039367B1 (de)
JP (1) JP4982739B2 (de)
AT (1) ATE506957T1 (de)
DE (1) DE602007014210D1 (de)
WO (1) WO2007138810A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9919010B2 (en) 2008-04-30 2018-03-20 Genomix Co., Ltd. Method for collecting functional cells in vivo with high efficiency
RU2599448C2 (ru) 2009-10-28 2016-10-10 Дженомикс Ко., Лтд. Средства для стимуляции регенерации тканей путем привлечения мезенхимных стволовых клеток и/или плюрипотентных стволовых клеток костного мозга в кровь
US10364276B2 (en) 2011-04-26 2019-07-30 StemRIM Inc. Peptide for inducing regeneration of tissue and use thereof
JP6253589B2 (ja) 2012-10-25 2017-12-27 株式会社ジェノミックス Ｈｍｇｂ１断片を利用した新規心筋梗塞の治療法
KR102146822B1 (ko) * 2012-10-25 2020-08-21 가부시키가이샤 스템림 Hmgb1 단편을 이용한 척수 손상에 대한 신규 치료법
US10989719B2 (en) 2013-10-11 2021-04-27 National University Corporation Tokyo Medical And Dental University Methods for treating spinocerebellar ataxia type I using RPA1
WO2018030405A1 (ja) * 2016-08-09 2018-02-15 国立大学法人東京医科歯科大学 Ｈｍｇｂ１に対する抗体、及びそれを含有するアルツハイマー病を治療又は予防するための組成物
JP6984815B2 (ja) * 2016-09-12 2021-12-22 国立大学法人 東京医科歯科大学 神経変性疾患タンパク質の異常凝集を伴って発症する神経疾患に対する予防又は治療剤、及び上記予防又は治療剤のスクリーニング方法
BR112019014921A2 (pt) 2017-01-27 2020-03-31 StemRIM Inc. Agente terapêutico para miocardiopatia, infarto antigo do miocárdio e insuficiência cardíaca crônica
EP3718561A4 (de) 2017-12-01 2021-07-21 Stemrim Inc. Therapeutikum für entzündliche darmerkrankung
WO2021242180A1 (en) * 2020-04-22 2021-12-02 Chulalongkorn University A composition and a method of rejuvenating dna and preventing dna damage

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4255101B2 (ja) 2002-03-15 2009-04-15 独立行政法人理化学研究所 神経変性疾患の治療薬
JP2006517537A (ja) * 2003-01-03 2006-07-27 アルケド バイオテック ゲーエムベーハー Ｄｎａ結合タンパク質の使用
WO2005025604A2 (en) * 2003-09-10 2005-03-24 The General Hospital Corporation Use of hmgb and hmgb fragments to decrease specific immune response
JP4792392B2 (ja) * 2003-09-11 2011-10-12 コーナーストーン セラピューティクス インコーポレイテッド Ｈｍｇｂ１に対するモノクローナル抗体
US7618793B2 (en) * 2004-10-20 2009-11-17 The Regents Of The University Of Washington Identifying agents for decreasing cellular toxicity associated with huntingin polypeptide

Also Published As

Publication number Publication date
US7833975B2 (en) 2010-11-16
EP2039367A1 (de) 2009-03-25
WO2007138810A1 (ja) 2007-12-06
JP2007320919A (ja) 2007-12-13
EP2039367A4 (de) 2009-12-30
EP2039367B1 (de) 2011-04-27
ATE506957T1 (de) 2011-05-15
US20090280488A1 (en) 2009-11-12
JP4982739B2 (ja) 2012-07-25

Similar Documents

Publication Publication Date Title
ATE506957T1 (de) Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen
DE602006017207D1 (de) Rekombinante n-glykosylierte proteine aus prokaryontischen zellen
MX2008009493A (es) Peptido novedoso y uso del mismo.
EA201170878A1 (ru) Полипептиды с ксиланазной активностью
WO2004078777A3 (en) Dipeptidyl-peptidase protected proteins
MX2009002816A (es) Proteinas de fusion de albumina.
MX2008001865A (es) Proteinas de fusion de albumina.
SE0301009D0 (sv) Novel compounds
HK1134283A1 (en) Arylsulfonamide compounds
SG170116A1 (en) Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
WO2007141274A3 (en) Human binding molecules having killing activity against staphylococci and uses thereof
EP2455459A3 (de) Lipasevarianten zur pharmazeutischen Verwendung
ATE417595T1 (de) Keratin-bindende polypeptide
NO20054769L (no) Substituerte fenylalkansyrer
IN2012DN03368A (de)
WO2008074840A3 (en) Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders
MY138708A (en) Biaryloxymethylarenecarboxylic acids
MX2009006617A (es) Composiciones que contienen, metodos que involucran y usos de aminoacidos y polipeptidos no naturales.
WO2011036443A9 (en) S1 protease c- terminal polypeptides and uses thereof for treating inflammation or coagulation disorders
WO2007132292A3 (en) Therapy for alzheimer's disease
WO2008051326A3 (en) Identification of contactins and l1- cams as ligands for the amyloid precursor protein
WO2006075253A3 (en) Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides.
WO2008047370A3 (en) Compositions and methods for inducing angiogenesis
WO2005059131A3 (en) Protein binding miniature proteins and uses thereof
HK1121383A1 (en) Wound healing agent and composition